Pfizer Inc. (NYSE:PFE) is without doubt one of the 7 Best Longevity Stocks to Buy Now.
On June 8, 2026, Pfizer Inc. (NYSE:PFE) introduced that the U.S. FDA permitted an expanded indication for Hympavzi to incorporate sufferers with hemophilia A or B 12 years and older with inhibitors and pediatric sufferers with or with out inhibitors. Hympavzi is now indicated within the U.S. for routine prophylaxis to stop or scale back bleeding episodes in adults and pediatric sufferers 6 years and older with hemophilia A with or with out issue VIII inhibitors, or hemophilia B with or with out issue IX inhibitors.
On June 7, 2026, Pfizer Inc. (NYSE:PFE) offered detailed Part 2b outcomes for berobenatide, an investigational month-to-month GLP-1 receptor agonist peptide, on the 86th Scientific Classes of the American Diabetes Affiliation. The corporate stated the VESPER-1, 2, and three research offered proof of idea for berobenatide as a possible first-in-class month-to-month GLP-1 RA peptide, confirmed favorable tolerability, and highlighted potential benefits from month-to-month supply and a 0.5 mL injection quantity.
On Could 31, 2026, Pfizer Inc. (NYSE:PFE) introduced detailed progression-free and total survival outcomes from Cohort 3 of the Part 3 Breakwater trial. Pfizer stated median progression-free survival was almost doubled with the BRAFTOVI mixture routine versus the comparator.
Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical merchandise in the USA and internationally.
Whereas we acknowledge the potential of PFE as an funding, we imagine sure AI shares supply higher upside potential and carry much less draw back threat. When you’re on the lookout for a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring pattern, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
